Short Interest in Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) Increases By 1,826.7%

Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) was the recipient of a significant growth in short interest in October. As of October 15th, there was short interest totalling 57,800 shares, a growth of 1,826.7% from the September 30th total of 3,000 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Kissei Pharmaceutical Stock Performance

Shares of OTCMKTS:KSPHF remained flat at $25.00 during trading on Friday. Kissei Pharmaceutical has a twelve month low of $19.32 and a twelve month high of $25.00. The company’s fifty day moving average price is $22.75 and its 200 day moving average price is $21.75.

About Kissei Pharmaceutical

Kissei Pharmaceutical Co, Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Kalogra tablets, for the treatment of ulcerative colitis; Tabuneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Malizeb tablets; Tavaris tablets for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia.